These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 22078297)

  • 1. Tissue inhibitors of metalloproteinases.
    Murphy G
    Genome Biol; 2011 Nov; 12(11):233. PubMed ID: 22078297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural basis of matrix metalloproteinases and tissue inhibitors of metalloproteinases.
    Maskos K; Bode W
    Mol Biotechnol; 2003 Nov; 25(3):241-66. PubMed ID: 14668538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of Tissue Inhibitors of Metalloproteinases in Organ Development and Regulation of ADAMTS Family Metalloproteinases in
    Kubota Y; Nishiwaki K; Ito M; Sugimoto A
    Genetics; 2019 Jun; 212(2):523-535. PubMed ID: 30992386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Designing TIMP (tissue inhibitor of metalloproteinases) variants that are selective metalloproteinase inhibitors.
    Nagase H; Brew K
    Biochem Soc Symp; 2003; (70):201-12. PubMed ID: 14587293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural basis of the matrix metalloproteinases and their physiological inhibitors, the tissue inhibitors of metalloproteinases.
    Bode W; Maskos K
    Biol Chem; 2003 Jun; 384(6):863-72. PubMed ID: 12887053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drosophila TIMP is a potent inhibitor of MMPs and TACE: similarities in structure and function to TIMP-3.
    Wei S; Xie Z; Filenova E; Brew K
    Biochemistry; 2003 Oct; 42(42):12200-7. PubMed ID: 14567681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MMP-TIMP interaction depends on residue 2 in TIMP-4.
    Stratmann B; Farr M; Tschesche H
    FEBS Lett; 2001 Nov; 507(3):285-7. PubMed ID: 11696356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The tissue inhibitors of metalloproteinases (TIMPs): an ancient family with structural and functional diversity.
    Brew K; Nagase H
    Biochim Biophys Acta; 2010 Jan; 1803(1):55-71. PubMed ID: 20080133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proinflammatory cytokines regulate tissue inhibitors of metalloproteinases and disintegrin metalloproteinase in cardiac cells.
    Li YY; McTiernan CF; Feldman AM
    Cardiovasc Res; 1999 Apr; 42(1):162-72. PubMed ID: 10435007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue inhibitor of metalloproteinases-4. The road less traveled.
    Melendez-Zajgla J; Del Pozo L; Ceballos G; Maldonado V
    Mol Cancer; 2008 Nov; 7():85. PubMed ID: 19025595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Many Facets of Metzincins and Their Endogenous Inhibitors: Perspectives on Ovarian Cancer Progression.
    Escalona RM; Chan E; Kannourakis G; Findlay JK; Ahmed N
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29393911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of TIMPs in regulation of extracellular matrix proteolysis.
    Arpino V; Brock M; Gill SE
    Matrix Biol; 2015; 44-46():247-54. PubMed ID: 25805621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and regulation of metalloproteinases and their inhibitors in intervertebral disc aging and degeneration.
    Vo NV; Hartman RA; Yurube T; Jacobs LJ; Sowa GA; Kang JD
    Spine J; 2013 Mar; 13(3):331-41. PubMed ID: 23369495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic interdomain interactions contribute to the inhibition of matrix metalloproteinases by tissue inhibitors of metalloproteinases.
    Remacle AG; Shiryaev SA; Radichev IA; Rozanov DV; Stec B; Strongin AY
    J Biol Chem; 2011 Jun; 286(23):21002-12. PubMed ID: 21518756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Threonine 98, the pivotal residue of tissue inhibitor of metalloproteinases (TIMP)-1 in metalloproteinase recognition.
    Lee MH; Rapti M; Knaüper V; Murphy G
    J Biol Chem; 2004 Apr; 279(17):17562-9. PubMed ID: 14734567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Matrix Metalloproteinases in Degenerative Kidney Disorders.
    Narula S; Tandon C; Tandon S
    Curr Med Chem; 2018; 25(15):1805-1816. PubMed ID: 29210632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue inhibitor of metalloproteinases (TIMPs) in heart failure.
    Moore L; Fan D; Basu R; Kandalam V; Kassiri Z
    Heart Fail Rev; 2012 Sep; 17(4-5):693-706. PubMed ID: 21717224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The role of matrix metalloproteinases and tissue inhibitors of metalloproteinases in invasion of tumours of neuroepithelial tissue].
    Bogaczewicz J; Jasielski P; Mosiewicz A; Trojanowski T; Suchozebrska-Jesionek D; Stryjecka-Zimmer M
    Neurol Neurochir Pol; 2006; 40(5):404-12. PubMed ID: 17103354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential gene expression profiling of metalloproteinases and their inhibitors: a comparison between bovine intervertebral disc nucleus pulposus cells and articular chondrocytes.
    Cui Y; Yu J; Urban JP; Young DA
    Spine (Phila Pa 1976); 2010 May; 35(11):1101-8. PubMed ID: 20473119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crystal structures of human ADAMTS-1 reveal a conserved catalytic domain and a disintegrin-like domain with a fold homologous to cysteine-rich domains.
    Gerhardt S; Hassall G; Hawtin P; McCall E; Flavell L; Minshull C; Hargreaves D; Ting A; Pauptit RA; Parker AE; Abbott WM
    J Mol Biol; 2007 Nov; 373(4):891-902. PubMed ID: 17897672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.